The three-day slide is over, but Wednesday’s rebound did not erase the market’s technical questions. The Dow Jones, S&P 500, and Nasdaq all finished higher as retreating Treasury yields gave equities a lift, ending three consecutive losing sessions and briefly shifting attention from selling pressure to the bond market.

That relief came with a clear catalyst and an obvious test ahead. The Treasury Department said it would increase long-term debt purchases, helping drive a concurrent bond rally and lower yields, while traders awaited Federal Reserve minutes that could shape the next move in risk sentiment. The rebound was broad enough to matter, but not definitive enough to settle the market’s direction.

According to Yahoo Finance’s market recap, the major U.S. equity benchmarks snapped their three-session losing streak on Wednesday. The move was reinforced by the bond market: yields slipped as the Treasury signaled increased purchases of long-term debt. That matters because rates remain a central transmission mechanism for equity valuations and trader positioning. When yields retreat, pressure on stocks may ease; when they rise, the market’s tolerance for uncertainty can narrow.

Moderna Provides the Upside Spark

Moderna ($MRNA) was the standout upside mover. The source description characterized the stock as “skyrocketing” in session trading, making it the clearest individual equity expression of Wednesday’s risk appetite. The move also underscored the uneven character of the session: broad indexes recovered, but the most dramatic action was concentrated in a named biotechnology stock rather than spread uniformly across the market.

For traders watching the major exchange-traded proxies, SPY, QQQ, and DIA offered the practical framework for reading the rebound. SPY tracks the S&P 500, QQQ reflects the Nasdaq-oriented growth complex, and DIA represents the Dow. The session’s gains indicate that all three market segments found support after the three-day decline, but the technical picture still calls for discipline rather than celebration.

7,700 Is the Immediate S&P 500 Marker

S&P 500 futures remained part of the market’s forward-looking focus, while the index held near 7,700. The level is important less as a victory lap than as a line in the sand following the recent weakness. FXEmpire identifies 7,600 and the rising 50-day exponential moving average as the next major support zone if the index comes under renewed pressure.

That support area gives traders a defined map for the next session. A continued hold above the nearby level could suggest that Wednesday’s rebound has room to develop. A move toward 7,600 and the rising 50-day EMA would place the market’s recovery claim under a more serious test. Neither outcome is predetermined, but the levels provide context that headlines alone cannot.

Nasdaq 100 Still Choppy

The Nasdaq 100’s price action remained choppy, even as technology-oriented equities participated in the broader rebound. Its corresponding support area is also identified around 7,600 and the rising 50-day EMA. That overlap with the S&P 500’s technical reference points makes the zone especially relevant for QQQ-focused traders: weakness there could signal that Wednesday’s rate-driven relief was temporary, while sustained stability could improve the tone.

Fed Minutes Are the Next Catalyst

The anticipated Fed minutes were the session’s most important unresolved catalyst. Traders were looking for fresh clues on the policy outlook and the central bank’s interpretation of economic conditions. With yields already retreating and stocks recovering, the minutes could either reinforce the bond-market tailwind or challenge the improved risk sentiment.

The bottom line: Wednesday stopped the slide, but it did not settle the trend. Falling yields provided the spark, Moderna supplied the drama, and 7,600 alongside the rising 50-day EMA now defines the technical downside zone to watch.